Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide

Molecular Microbiology

Volumn 42, Issue 2, 2001, Pages 453-467

  Janbon, Guilhem ^a   Himmelreich, Uwe ^b   Moyrand, Frédérique ^a   Improvisi, Luce ^a   Dromer, Françoise ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLUCURONOXYLOMANNANS; GLYCOSYLTRANSFERASE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; POLYSACCHARIDE; PROTEIN CAS1P; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ACETYLATION; AMINO ACID SEQUENCE; ARABIDOPSIS; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DROSOPHILA; GENETIC COMPLEMENTATION; GENOME; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; SEQUENCE ANALYSIS;

ACETYLATION; AMINO ACID SEQUENCE; ANIMALS; CARBOHYDRATE SEQUENCE; CLONING, MOLECULAR; CRYPTOCOCCUS NEOFORMANS; FUNGAL PROTEINS; GENETIC COMPLEMENTATION TEST; GLYCOSYLTRANSFERASES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTATION; POLYSACCHARIDES; SEQUENCE HOMOLOGY, AMINO ACID; SEROTYPING; VIRULENCE;

ARABIDOPSIS; ARABIDOPSIS THALIANA; FILOBASIDIELLA NEOFORMANS;

EID: 0034768441     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.2001.02651.x     Document Type: Article

References (82)

1. Cryptococcus neoformans mating and virulence are regulated by the G-protein α subunit GPA1 and cAMP
2. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy
3. Cryptococcus neoformans polysaccharide: Studies on serologic properties and role in infection
4. Identification of a gene essential for O-acetylation of the Staphylococcus aureus type 5 capsular polysaccharide
5. What makes Cryptococcus neoformans a pathogen?
6. The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies
7. Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells
8. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence
9. Isolation of the third capsule-associated gene CAP60, required for virulence in Cryptococcus neoformans
10. Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans
11. The second capsule gene of Cryptococcus neoformans CAP64, is essential for virulence
12. Polysaccharide antigens of the capsule of Cryptoccocus neoformans
13. 13C-NMR spectroscopy
14. Facilitated isolation, purification and analysis of glucuronoxylomannan of Cryptococcus neoformans
15. 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network
16. In vitro and in vivo stability of Cryptococcus neoformans glucuronoxylomannan epitope that elicits protective antibodies
17. Conserved cAMP signaling cascades regulate fungal development and virulence
18. Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans
19. A comprehensive set of sequence analysis programs for the VAX
20. A unique α-1,3 mannosyltransferase of the pathogenic fungus Cryptococcus neoformans
21. How does Cryptococcus get its coat?
22. Production, characterization, and antibody specificity of a mouse antibody reactive with Cryptococcus neoformans capsular polysaccharide
23. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide
24. Individual and environmental factors associated with Cryptococcus neoformans serotype D in France
25. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation
26. Identification of algI and algJ in the Pseudomonas aeriginosa alginate gene cluster which are required for alginate O-acetylation
27. Cryptococcus neoformans var. grubii: Separate status for Cryptococcus neoformans serotype A isolates
28. Bacterial alginate biosynthesis-recent progress and future prospects
29. Epidemiological evidence for dormant Cryptococcus neoformans infection
30. Nucleotide sequence and genome organization of biologically active proviruses of the bovine immunodeficiency-like virus
31. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide
32. Studies on transformation of Escherichia coli with plasmids
33. A sequence property approach to searching protein databases
34. Production of agglutinating monoclonal antibody against antigen 8 specific for Cryptococcus neoformans serotype D
35. PMT3 and PMT4, two new members of the protein-O-mannosyltransferase gene family of Saccharomyces cerevisiae
36. Cryptococcal UDP-glucose dehydrogenase: Enzymatic control of capsular biosynthesis
37. UDP-glucuronate decarboxylase and synthesis of capsular polysaccharide in Cryptococcus neoformans
38. Strains of Cryptococcus neoformans with defined capsular phenotypes
39. Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans
40. O-acelylation of sialic acids
41. 9-O-acetyl-sialic acids have widespread but selective expression: Analysis using a chimeric dual-function probe derived from influenza C hemmagglutinin-esterase
42. Epidemiologic differences between the two varieties of Cryptococcus neoformans
43. Taxonomic studies of Fillobasidiella species and their anamorphs
44. Cryptococcal glucuronoxylomannan induces interleukin IL-8 production by human microglia but inhibits neutrophil migration toward IL-8
45. Fungemia during cryptococcosis sheds some light on pathophysiology
46. Cytokine profiles of AIDS patients are similar to those of mice with disseminated Cryptococcus neoformans infection
47. Homology between a genetic locus (mdoA) involved in the osmoregulated biosynthesis of periplasms glucans in Escherichia coli and a genetic locus (hrpM) controlling pathogenicity of Pseudomonas syringae
48. Protein O-glycosylation in yeast. The PMT2 gene specifies a second protein O-mannosyltransferase that functions in addition to the PMT1-encoded activity
49. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium
50. The α-mating type locus of Cryptococcus neoformans contains a peptide pheronome gene
51. Molecular analysis of a pathogenicity locus in Pseudomonas syringae pv
52. Identification of virulence mutants of the fungal pathogen Cryptococcus neoformans using signature-tagged mutagenesis
53. Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia
54. O-acetylation of plant cell wall polysaccharides: Identification and partial characterization of a rhamnogalacturonan O-acetyl-transferase from potato suspension-cultured cells
55. Identification and specificities of N-terminal acetyltransferases from Saccharomyces cerevisiae
56. The acetyl substituent of succinoglycan is not necessary for alfalfa nodule invasion by Rhizobium meliloti Rm1021
57. Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection
58. Identification and characterization of genes induced during sexual differentiation in Schizosaccharomyces pombe
59. Gitelman's variant of the Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter
60. Structure of the de-O-acetylated glucuronoxylomannan from Cryptoccocus neoformans serotype, as determined by 2D NMR spectroscopy
61. Acetylation (O-factor 5) affects the structural and immunological properties of Salmonella typhimurium lipopolysaccharide O antigen
62. Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A
63. Analysis of the Escherichia coli genome. V. DNA sequence of the region from 76.0 to 81.5 minutes
64. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans
65. A new gene required for cellulose production and a gene encoding cellulolytic activity in Acetobacter xylinum are colocalized with the bcs operon
66. PMT1, the gene for a key enzyme of protein O-glycosylation in Saccharomyces cerevisiae
67. Protein O-mannosylation
68. Molecular analysis of the Cryptococcus neoformans ADE2 gene, a selectable marker for transformation and gene disruption
69. Diversity in the sialic acids
70. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold
71. Differences in Cryptococcus neoformans capsular polysaccharide structure influence assembly of alternative complement pathway C3 convertase on fungal surfaces
72. Side group addition by xylosyltransferase and glucuronyltransferase in the biosynthesis of capsular polysaccharide in Cryptococcus neoformans
73. The Cryptococcus neoformans GAL7 gene and its use as an inductible promoter
74. Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans
75. Genetic organization of the cellulose synthase operon in Acetobacter xylinum
76. Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans